scispace - formally typeset
Journal ArticleDOI

Efficacy and safety of levosulpiride versus haloperidol injection in patients with acute psychosis: A randomized double-blind study

Reads0
Chats0
TLDR
Haloperidol was more effective than levosulpiride injection for psychotic symptoms, aggression, and severity of agitation in acute psychosis, but extrapyramidal adverse effects were less frequent with levosULpiride as compared with those receiving haloperidl.
Abstract
Background: Injectable antipsychotics are frequently required for controlling agitation and aggression in acute psychosis. No study has examined the use of injectable levosulpiride for this indication. Objective: To compare the efficacy and safety of injectable levosulpiride and haloperidol in patients with acute psychosis. Methods: This was a randomized, double-blind, parallel-group study in which 60 drug-naive patients having acute psychosis were randomly assigned to receive either intramuscular haloperidol (10–20 mg/d) or levosulpiride (25–50 mg/d) for 5 days. All patientswere rated on Brief Psychiatric Rating Scale (BPRS), Overt Agitation Severity Scale (OASS), Overt Aggression Scale–Modified (OAS-M) scores, Simpson Angus Scale (SAS), and Barnes Akathisia Rating Scale (BARS). Results: Repeated-measures ANOVA for BPRS scores showed significant effect of time (P < 0.001) and a trend toward greater reduction in scores in haloperidol group as shown by group � time interaction (P = 0.076). Repeated-measures ANOVA for OASS showed significant effect of time (P < 0.001) but no group � time interaction. Repeatedmeasures ANOVA for OAS-M scores showed significant effect of time (P < 0.001) and greater reduction in scores in haloperidol group as shown by group � time interaction (P = 0.032). Lorazepam requirement was much lower in haloperidol group as compared with those receiving levosulpiride (P = 0.022). Higher rates of akathisia and extrapyramidal symptoms were noted in the haloperidol group. Conclusions: Haloperidol was more effective than levosulpiride injection for psychotic symptoms, aggression, and severity of agitation in acute psychosis, but extrapyramidal adverse effects were less frequent with levosulpiride as compared with those receiving haloperidol.

read more

Citations
More filters
Journal Article

A rating scale for drug-induced akathisia

TL;DR: A rating scale for drug-induced akathisia has been derived that incorporates diagnostic criteria for pseudoakathisio, and mild, moderate, and severe akath isia, and there is an item for rating global severity.
Journal ArticleDOI

Development of levosulpiride-loaded solid lipid nanoparticles and their in vitro and in vivo comparison with commercial product

TL;DR: It can be concluded that SLNs are capable to improve the dissolution and bioavailability of levosulpiride, even more than the commercial product.
Journal ArticleDOI

Levosulpiride-loaded nanostructured lipid carriers for brain delivery with antipsychotic and antidepressant effects.

TL;DR: In this paper , the potential of levosulpiride-loaded nanostructured lipid carriers (LEVO-NLCs) for effective brain delivery with anti-psychotic and antidepressant effects was investigated.
Journal ArticleDOI

Levosulpiride Relieved Persistent Hiccups in a Patient With COVID-19 and Vascular Cognitive Impairment.

TL;DR: In this article, a 62-year-old man with severe acute respiratory syndrome coronavirus 2 (COVID-19) pneumonia was treated with levomepromazine 25 mg by mouth, but sedation and delirium impeded the continuation of treatment, which only reduced the frequency of hiccup spells by about 25%.
Journal Article

Pharmacological Management of Agitation and Aggression in Emergency Department

TL;DR: It is recommended that pharmacological treatments, such as antipsychotics, ketamine, promethazine, on-steroidal anti-inflammatory drugs, analgesics, narcotics may create more treatment option for the management of agitation and aggression in ED that requires more studies in order to show their risks and benefits.
References
More filters
Journal ArticleDOI

The Brief Psychiatric Rating Scale

TL;DR: The Brief Psychiatric Rating Scale (BRS) as mentioned in this paper was developed to provide a rapid assessment technique particularly suited to the evaluation of patient change, and it is recommended for use where efficiency, speed, and economy are important considerations.
Journal ArticleDOI

A rating scale for extrapyramidal side effects

TL;DR: A modification of an earlier rating scale for extrapyramidal system disturbance is described, and evidence for the validity and reliability of the scale is presented.
Journal Article

A rating scale for drug-induced akathisia

TL;DR: A rating scale for drug-induced akathisia has been derived that incorporates diagnostic criteria for pseudoakathisio, and mild, moderate, and severe akath isia, and there is an item for rating global severity.
Journal ArticleDOI

A rating scale for drug-induced akathisia.

TL;DR: A rating scale for drug-induced akathisia has been derived that incorporates diagnostic criteria for pseudoakathisias, and mild, moderate, and severe AKA as discussed by the authors.
Journal ArticleDOI

Pharmacological Management of Acute Agitation

TL;DR: Current clinical experience and one naturalistic study with intramuscular ziprasidone suggest that it is efficacious and can be safely used in patients with known QTc interval-associated conditions, and these atypical antipsychotics may represent a historical advance in the treatment of acute agitation.
Related Papers (5)